This site uses cookies.
Some of these cookies are essential to the operation of the site,
while others help to improve your experience by providing insights into how the site is being used.
For more information, please see the ProZ.com privacy policy.
Freelance translator and/or interpreter, Verified member
Data security
This person has a SecurePRO™ card. Because this person is not a ProZ.com Plus subscriber, to view his or her SecurePRO™ card you must be a ProZ.com Business member or Plus subscriber.
Affiliations
This person is not affiliated with any business or Blue Board record at ProZ.com.
Spanish to Italian - Rates: 0.06 - 0.07 EUR per word / 25 - 30 EUR per hour English to Italian - Rates: 0.06 - 0.07 EUR per word / 25 - 30 EUR per hour German to Italian - Rates: 0.06 - 0.07 EUR per word / 25 - 30 EUR per hour
Source text - English Novel Molecule Combinations
Early results from the Phase Ib/IIa trial assessing the safety and activity of XXX combined with the novel small-molecule STAT3 inhibitor YYY or CXCR2 antagonist KKK in patients with advanced cancers also showed encouraging anti-tumour activity for the two new potential medicines in combination. Among patients receiving XXX plus YYY (n=11), two patients achieved a partial response, and five patients demonstrated stable disease. Among patients receiving KKK (n=20), one patient demonstrated complete response, two patients demonstrated partial response, and five patients demonstrated stable disease. Both arms determined the recommended dose for Phase II trials.
Translation - Italian Nuove combinazioni di molecole
I risultati iniziali del trial di Fase Ib/IIa, che verificava la sicurezza e l’attività del XXX combinato con il nuovo YYY (inibitore di STAT3) o con KKK (antagonista di CXCR2) a piccole molecole nei pazienti con carcinoma avanzato, hanno mostrato un’attività anti-tumorale incoraggiante della combinazione di questi due nuovi potenziali farmaci. Tra tutti i pazienti che hanno ricevuto XXX e YYY (n=11), due pazienti hanno ottenuto una risposta parziale e cinque pazienti hanno mostrato una malattia stabile. Tra tutti i pazienti che hanno ricevuto KKK (n=20), un paziente ha ottenuto una risposta completa, due pazienti hanno ottenuto una risposta parziale e cinque pazienti hanno mostrato una malattia stabile. Entrambi i bracci hanno determinato la dose raccomandata per il trial di Fase II.
More
Less
Translation education
Master's degree - Università di Modena e Reggio Emilia
Experience
Years of experience: 13. Registered at ProZ.com: Feb 2013. Became a member: Jun 2013.
Credentials
English to Italian (MA Medical and Pharmaceutical Translation - CTI – Communication Trend Italia , verified)
Memberships
N/A
Software
Adobe Acrobat, DejaVu, memoQ, Microsoft Excel, Microsoft Word, Powerpoint, Trados Studio
Member since Jun '13
Expertise 
Portfolio